Search Results - "Rodés, Berta"

Refine Results
  1. 1

    Ageing with HIV: Challenges and biomarkers by Rodés, Berta, Cadiñanos, Julen, Esteban-Cantos, Andrés, Rodríguez-Centeno, Javier, Arribas, José Ramón

    Published in EBioMedicine (01-03-2022)
    “…The antiretroviral treatment (ART) developed to control HIV infection led to a revolution in the prognosis of people living with HIV (PLWH). PLWH underwent…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Susceptibility to protease inhibitors in HIV-2 primary isolates from patients failing antiretroviral therapy by Rodés, Berta, Sheldon, Julie, Toro, Carlos, Jiménez, Victoria, Álvarez, Miguel Ángel, Soriano, Vincent

    Published in Journal of antimicrobial chemotherapy (01-04-2006)
    “…Background: Current protease inhibitors (PIs) are designed against HIV-1, and information on their performance against HIV-2 clinical isolates is scarce…”
    Get full text
    Journal Article
  7. 7

    Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenofovir by SHELDON, Julie, CAMINO, Nuria, LOCARNINI, Stephen, SORIANO, Vincent, RODES, Berta, BARTHOLOMEUSZ, Angeline, KUIPER, Michael, TACKE, Frank, NUNEZ, Marina, MAUSS, Stefan, LUTZ, Thomas, KLAUSEN, Gerd

    Published in Antiviral therapy (01-01-2005)
    “…Tenofovir (TDF) is an adenosine nucleotide analogue that has been approved for the treatment of HIV-1 infection. It also shows activity against hepatitis B…”
    Get full text
    Journal Article
  8. 8

    Differences in disease progression in a cohort of long-term non-progressors after more than 16 years of HIV-1 infection by RODES, Berta, TORO, Carlos, PAXINOS, Ellen, POVEDA, Eva, MARTINEZ-PADIAL, Manuel, BENITO, José Miguel, JIMENEZ, Victoria, WRIN, Terri, BASSANI, Sylvina, SORIANO, Vincent

    Published in AIDS (London) (21-05-2004)
    “…It is unclear whether resistance to immunologic damage in long-term non-progressors (LTNP) will last indefinitely or whether it merely represents the extreme…”
    Get full text
    Journal Article
  9. 9

    Rapid development of subacute myelopathy in three organ transplant recipients after transmission of human T-cell lymphotropic virus type I from a single donor by TORO, Carlos, RODES, Berta, POVEDA, Eva, SORIANO, Vincent

    Published in Transplantation (15-01-2003)
    “…Human T-cell lymphotropic virus type I (HTLV-I) causes a subacute myelopathy in less than 5% of chronic carriers. However, the risk of neurologic disease…”
    Get full text
    Journal Article
  10. 10

    Quantitative Detection of Plasma Human Immunodeficiency Virus Type 2 Subtype A RNA by the Nuclisens EasyQ Assay (Version 1.1) by Rodés, Berta, Sheldon, Julie, Toro, Carlos, Cuevas, Laureano, Pérez-Pastrana, Esperanza, Herrera, Inmaculada, Soriano, Vincent

    Published in Journal of Clinical Microbiology (01-01-2007)
    “…No commercial viral load assay has yet been approved for use for measurement of human immunodeficiency virus type 2 (HIV-2) RNA levels in plasma. We assessed…”
    Get full text
    Journal Article
  11. 11

    Emergence of Drug Resistance Mutations in Human Immunodeficiency Virus Type 2-Infected Subjects Undergoing Antiretroviral Therapy by RODES, B, HOLGUIN, A, SORIANO, V, DOURANA, M, MANSINHO, K, ANTUNES, F, GONZALEZ-LAHOZ, J

    Published in Journal of Clinical Microbiology (01-04-2000)
    “…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  12. 12

    Risk of selecting K65R in antiretroviral-naive HIV-infected individuals with chronic hepatitis B treated with adefovir by SHELDON, Julie A, CORRAL, Angélica, RODES, Berta, MAUSS, Stefan, ROCKSTROH, Juergen, BERGER, Florian, SCHWARZE-ZANDER, Carolynne, SORIANO, Vincent

    Published in AIDS (London) (18-11-2005)
    “…Seven antiretroviral-naive HIV-infected individuals with chronic hepatitis B treated with adefovir for longer than 6 months were assessed. Using bulk…”
    Get full text
    Journal Article
  13. 13

    High rate of proV47A selection in HIV-2 patients failing lopinavir-based HAART by RODES, Berta, TORO, Carlos, SHELDON, Julie A, JIMENEZ, Victoria, MANSINHO, Kamal, SORIANO, Vincent

    Published in AIDS (London) (02-01-2006)
    “…We describe the emergence of the proV47A mutation in three out of five HIV-2-infected individuals failing lopinavir/ritonavir-based HAART. The appearance of…”
    Get full text
    Journal Article
  14. 14

    Enfuvirtide is active against HIV type 1 group O by Poveda, Eva, Barreiro, Pablo, Rodés, Berta, Soriano, Vincent

    Published in AIDS research and human retroviruses (01-06-2005)
    “…A high diversity within the HR1/HR2 regions of viral gp41 and one natural change (N42D) within the 36-45 aa domain in HIV-1 group O in comparison with HIV-1…”
    Get more information
    Journal Article
  15. 15

    Evolution of genotypic and phenotypic resistance to Enfuvirtide in HIV-infected patients experiencing prolonged virologic failure by Poveda, Eva, Rodés, Berta, Labernardière, Jean-Louis, Benito, José Miguel, Toro, Carlos, González-Lahoz, Juan, Faudon, Jean-Louis, Clavel, François, Schapiro, Jonathan, Soriano, Vincent

    Published in Journal of medical virology (01-09-2004)
    “…Four heavily antiretroviral‐experienced HIV‐infected patients had significant plasma HIV‐RNA reductions (>1 log) after beginning an Enfuvirtide (ENF)‐based…”
    Get full text
    Journal Article
  16. 16

    Evolution of the gp41 env region in HIV-infected patients receiving T-20, a fusion inhibitor by POVEDA, Eva, RODES, Berta, TORO, Carlos, MARTIN-CARBONERO, Luz, GONZALEZ-LAHOZ, Juan, SORIANO, Vincent

    Published in AIDS (London) (27-09-2002)
    “…T-20 belongs to a new family of antiretroviral drugs that inhibits HIV entry. Resistance may develop in vitro as result of changes within the GIV motif of the…”
    Get full text
    Journal Article
  17. 17

    Can the Level of Immunosuppression in Human Immunodeficiency Virus-Infected Patients Affect the Reliability of Human T-Cell Lymphotropic Virus Type 2 Serological Diagnosis? by Bassani, Sylvina, Toro, Carlos, Jiménez, Victoria, Rodés, Berta, Soriano, Vincent

    Published in Clinical and Vaccine Immunology (01-01-2006)
    “…Classifications Services CVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  18. 18

    Rapid Assessment of Phenotypic Resistance to Protease Inhibitors in Human Immunodeficiency Virus Type 1 Group O by RODES, Berta, POVEDA, Eva, SORIANO, Vincent

    Published in Journal of Clinical Microbiology (01-11-2002)
    “…Erratum ( vol. 41 , p. 527 ) Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg…”
    Get full text
    Journal Article
  19. 19
  20. 20